TSE:HHL ETF Price & Analysis
HHL ETF Chart & Stats
C$7.17
--
Market closed
C$7.17
--
Day’s Range― - ―
52-Week RangeC$6.86 - C$7.99
Previous CloseC$7.17
VolumeN/A
Average Volume (3M)373.63K
AUM1.62B
NAV7.19
Expense Ratio1.06%
Holdings Count24
Beta0.68
Inception DateNov 19, 2014
Last Dividend Ex-Date
Mar 31, 2026Dividend Yield
(10.04%)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume323,041
30 Day Avg. Volume373,627
AlphaN/A
ETF Overview
Healthcare LdrIncmUn
Healthcare LdrIncmUn (TSE:HHL) is a dynamic exchange-traded fund (ETF) that offers investors targeted exposure to the ever-evolving healthcare sector. As a sector-focused fund, HHL is specifically designed for those looking to capitalize on the growth and innovation within the global healthcare industry, a crucial component of the economy known for its resilience and potential for substantial returns. This ETF provides a unique blend of income and growth by investing in a diversified portfolio of healthcare leaders, ranging from pharmaceuticals and biotechnology to medical devices and healthcare providers. By focusing on a broad-based niche within the healthcare sector, HHL enables investors to tap into the diverse opportunities presented by cutting-edge technologies, groundbreaking research, and the increasing demand for healthcare services worldwide. With its strategic approach, Healthcare LdrIncmUn stands out as a compelling choice for investors seeking to enhance their portfolios with the robust potential of the healthcare industry.
Healthcare LdrIncmUn (HHL) Fund Flow Chart
Healthcare LdrIncmUn (HHL) 1 year Net Flows: C$359M
HHL ETF News
HHL ETF FAQ
What was TSE:HHL’s price range in the past 12 months?
TSE:HHL lowest ETF price was C$6.86 and its highest was C$7.99 in the past 12 months.
What is the AUM of TSE:HHL?
As of Apr 08, 2026 The AUM of TSE:HHL is 1.62B.
Is TSE:HHL overvalued?
According to Wall Street analysts TSE:HHL’s price is currently Undervalued.
Does TSE:HHL pay dividends?
TSE:HHL pays a Monthly dividend of C$0.06 which represents an annual dividend yield of 10.04%. See more information on TSE:HHL dividends here
How many shares outstanding does TSE:HHL have?
Currently, no data Available
Which hedge fund is a major shareholder of TSE:HHL?
Currently, no hedge funds are holding shares in TSE:HHL
HHL ETF Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Merck & Company
5.74%
AstraZeneca plc
5.67%
Johnson & Johnson
5.62%
Abbvie
5.57%
Bristol-Myers Squibb Company
5.48%
Amgen Inc
5.47%
Novartis AG
5.46%
Zoetis
5.06%
Abbott Laboratories
5.04%
Unitedhealth Group Inc.
5.03%
Total54.16%
See All Holdings


